Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, PK and PD of AZD5718 in healthy male subjects with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• AZD5718 (AZD5718)

Snippet

Sponsor: AstraZeneca | Conditions: Healthy Male Subjects, Cardiovascular Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-03-21